Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER4 | P35408 | 19/20 | 0.43 |
| ▸ | PTGER3 | P43115 | 4/20 | 0.43 |
| ▸ | PTGER2 | P43116 | 5/20 | 0.39 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.35 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.35 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3136527 | 0.90 | PTGER4 (0.45) | PTGER4PTGER3PTGER2 | |
| SCHEMBL2209847 | 0.86 | PTGER4 (0.45) | PTGER4PTGER3PTGER2 | |
| SCHEMBL2209857 | 0.86 | PTGER4 (0.45) | PTGER4PTGER3PTGER2 | |
| SCHEMBL2212183 | 0.82 | PTGER4 (0.58) | PTGER4PTGER3PTGER2 | |
| SCHEMBL2212180 | 0.82 | PTGER4 (0.58) | PTGER4PTGER3PTGER2 | |
| SCHEMBL3136075 | 0.78 | PTGER4 (0.70) | PTGER4PTGER3PTGER2 | |
| SCHEMBL2205865 | 0.78 | PTGER4 (0.70) | PTGER4PTGER3PTGER2 | |
| SCHEMBL2205857 | 0.78 | PTGER4 (0.70) | PTGER4PTGER3PTGER2 | |
| SCHEMBL2208514 | 0.76 | PTGER4 (0.53) | PTGER4PTGER3PTGER2 | |
| SCHEMBL2212442 | 0.76 | PTGER4 (0.64) | PTGER4PTGER3PTGER2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1613621-B1 | PROSTAGLANDIN ANALOGS AS EP4 RECEPTOR AGONISTS | MERCK FROSST CANADA LTD (CA) | 2010-07-21 | — | — | EP | claimed |